Demand
Download report
Favorite
Events Timeline
Commercial
Clinical
Drug
Target
Variants
Financial
Trends
Safety
Events Timeline
5D
1M
3M
6M
YTD
1Y
2Y
5Y
Max
Events
FDA approval date
EMA approval date
Patent expiration date
Study first post date
Last update post date
Start date
Primary completion date
Completion date
Results first post date
Plot placeholder
Mock data
Subscribe for the real data
Commercial
No data
Clinical
Clinical Trials
1290 clinical trials
View more details
Plot placeholder
Mock data
Subscribe for the real data
Indications Phases 4
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Hemophilia aD006467EFO_0007267D6651461928106
Erectile dysfunctionD007172EFO_0004234F52.21171412940
Hemophilia bD002836—D6726271738
Postoperative painD010149—G89.1811672034
Hepatocellular carcinomaD006528—C22.0—1091929
PainD010146EFO_0003843R52—1361828
Diabetes mellitusD003920EFO_0000400E08-E131—212428
CarcinomaD002277—C80.0—781824
Liver neoplasmsD008113EFO_1001513C22.0—761721
Breast neoplasmsD001943EFO_0003869C5011—11518
Show 80 more
Indications Phases 3
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
DepressionD003863—F33.9—11—3233
Hiv infectionsD015658EFO_0000764B20123—1521
ObesityD009765EFO_0001073E66.9——1—1819
Low back painD017116—M54.5——3—1417
Back painD001416—M54——3—1417
Anxiety disordersD001008EFO_0006788F41.1—11—1617
HemorrhageD006470MP_0001914R58116—815
Chronic painD059350————5—712
Smoking cessationD016540EFO_0004319——21—1012
Type 2 diabetes mellitusD003924EFO_0001360E11——1—1011
Show 64 more
Indications Phases 2
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
StrokeD020521EFO_0000712I63.922——3336
Mental disordersD001523EFO_0000677F91.9—1——1718
NeoplasmsD009369—C80—1——1011
Heart failureD006333EFO_0003144I5011——810
MalnutritionD044342EFO_0008572E40-E46—1——78
AnesthesiaD000758——11——56
Cigarette smokingD000073865——11——46
VapingD000072137——11——35
Neoplasm metastasisD009362EFO_0009708——2——24
Ocular motility disordersD015835EFO_1001990H50.54—1——34
Show 32 more
Indications Phases 1
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Cognitive dysfunctionD060825—G31.841———2627
Chronic obstructive pulmonary diseaseD029424EFO_0000341J44.92———1315
Type 1 diabetes mellitusD003922EFO_0001359E101———1314
Obstructive lung diseasesD008173——1———1011
Parkinson diseaseD010300EFO_0002508G201———910
MelanomaD008545——1———34
ContraceptionD003267——1———34
Tobacco useD064424—Z72.02———13
AnemiaD000740EFO_0004272D64.91———23
Ear diseasesD004427EFO_1001455H93.91———12
Show 16 more
Indications Without Phase
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Depressive disorderD003866EFO_1002014F32.A————1919
FatigueD005221—R53.83————1313
DementiaD003704EFO_0003862F03————1313
SchizophreniaD012559EFO_0000692F20————1313
Lung diseasesD008171EFO_0003818J98.4————1111
Brain injuriesD001930—S06.9————1010
Psychotic disordersD011618—F20.81————1010
Colorectal neoplasmsD015179——————99
Covid-19D000086382—U07.1————88
Traumatic brain injuriesD000070642—S06————88
Show 546 more
Epidemiology
Epidemiological information for investigational and approved indications
View more details
Drug
General
Drug common name—
INN—
Description
—
Classification
Unknown
Drug class—
Image (chem structure or protein)Loading
Structure (InChI/SMILES or Protein Sequence)—
Identifiers
PDB—
CAS-ID—
RxCUI—
ChEMBL ID—
ChEBI ID—
PubChem CID—
DrugBank—
UNII ID—
Target
No data
Variants
No data
Financial
No data
Trends
No data
Safety
Black-box Warning
No Black-box warning
Adverse Events
0 adverse events reported
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use